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Is the villin defect described by Phillips and colleagues
cause or consequence of the cholestatic liver disease?
Unfortunately Phillips’ group did not analyse the villin gene
in their patients. Some infectious diseases may cause
disruption of villin expression.8 Whether villin might also be
a target for viruses is not known. Thus, although the villin
defect described by Phillips and colleagues is highly
interesting, the question remains whether this defect is
genetic or perhaps acquired during embryogenesis. Also the
possibility that the defect is secondary to cholestasis cannot
be ruled out.
We have no conflict of interest to declare. 
*Peter L M Jansen, Ekkehard Sturm
Department of Hepatology and Gastroenterology and *Department of
Pediatrics, University Hospital Groningen, 9713 GZ Groningen, Netherlands 
(e-mail: p.l.m.jansen@int.azg.nl 
1 Laurent J, Gauthier F, Bernard O, et al. Long-term outcome after
surgery for biliary atresia: study of 40 patients surviving for more than 
10 years. Gastroenterology 1990; 99: 1793–97.
2 Perlmutter DH, Shepherd RW. Extrahepatic biliary atresia: a disease or
a phenotype? Hepatology 2002; 35: 1297–304.
3 Chen L, Goryachev A, Sun J, et al. Altered expression of genes 
involved in hepatic morphogenesis and fibrogenesis are identified 
by cDNA microarray analysis in biliary atresia. Hepatology 2003; 38:
567–76.
4 Friederich E, Vancompernolle K, Louvard D, Vandekerckhove J. Villin
function in the organization of the actin cytoskeleton: correlation of in
vivo effects to its biochemical activities in vitro. 
J Biol Chem 1999; 274: 26751–60.
5 Ferrary E, Cohen-Tannoudji M, Pehau-Arnaudet G, et al. In vivo, villin
is required for Ca(2+)-dependent F-actin disruption in intestinal brush
borders. J Cell Biol 1999; 146: 819–30.
6 Pinson KI, Dunbar L, Samuelson L, Gumucio DL. Targeted disruption
of the mouse villin gene does not impair the morphogenesis of microvilli.
Dev Dyn 1998; 211: 109–21.
7 Athman R, Louvard D, Robine S. Villin enhances HGF-induced actin
cytoskeleton remodeling in epithelial cells. Mol Biol Cell Aug 22, 2003.
DOI: 10.1091/mbc.E03-02-0091.
8 Lauwaet T, Oliveira MJ, Callewaert B, et al. Proteolysis of enteric cell
villin by Entamoeba histolytica cysteine proteinases. 
J Biol Chem 2003; 278: 22650–56. 
9 Athman R, Louvard D, Robine S. The epithelial cell cytoskeleton and
intracellular trafficking III: how is villin involved in the actin cytoskeleton
dynamics in intestinal cells? Am J Physiol Gastrointest Liver Physiol 2002;
283: G496–G502.
THE LANCET • Vol 362 • October 4, 2003 • www.thelancet.com 1091
COMMENTARY
Urban health: a new discipline
City living is a reality for many and is rapidly becoming so
for most of the world’s population. More than half the
world’s population will be living in urban areas before the
end of this decade and nearly two-thirds will live in urban
areas within 30 years.1 Although North America and
Europe are the world’s most urbanised regions, most of the
global urban population is on other continents. In 2000, the
number of urban dwellers in the least urbanised region,
Asia, was already greater than the urban population in
North America and Europe combined, and most of the
growth in urban populations will take place in less wealthy
regions, particularly in Asia and Africa.2,3
Why should health professionals take a particular interest
in urban living? Urban living has long been associated with
health, both positively and negatively. In the world’s
wealthier countries, cities in the 19th and at the turn of the
20th century were plagued by infectious diseases associated
with crowding.4 Epidemics of influenza, typhus, and
tuberculosis killed millions of people in cities with poor
sanitation and squalid living conditions. After a revival in
the quality of most cities in the developed world in the
middle of the 20th century, recent history has seen growing
disparities in the health of urban residents compared with
suburban and rural populations. The emerging HIV
epidemic and a rise in violence in the 1980s exacerbated the
burden of disease in many cities.5,6 Terms such as urban
penalty have been proposed to account for this excess
burden of disease.7 In less wealthy countries, infectious
diseases were the largest contributors to morbidity and
mortality in urban areas throughout the 20th century.8,9
However, at the end of that century, a growing middle-class
in many of these cities was accompanied by a rise in chronic
diseases, resulting in a double burden of disease affecting
many of the world’s most populous cities.8 On the other
hand, many public-health interventions have been imple-
mented primarily in cities, and specialised medical care is
often found in cities rather than in less urban areas.
Although public-health interventions have long had a
role in the control of disease in cities,4,5 research about the
features of modern urban areas and the facets of urban
living that influence health has been sparse. During the past
several decades, much research has focused on documen-
ting the burden of disease in inner-city areas. Different
academic disciplines have studied the health of
marginalised groups without fully exploring the role that
the urban context itself played both in the groups’
marginalisation and in shaping the health of these
populations. For example, much research about the health
of drug users, particularly into the spread of HIV and other
infectious diseases, has explored individual risk-behaviours
that are important within this group, but often with a
limited focus on how living in cities affected these risk
behaviours.
A small but growing body of work now recognises that
the role that the urban environment has in shaping health
and disease is itself of interest.10 Understanding the urban
factors that are risk or protective factors for health can
capitalise on the positive aspects of urban living and lead 
to the development of appropriate interventions and pre-
ventive measures. Given the growing predominance of
urban living, interventions that take into account features of
the urban environment have the potential to be widely
applicable and to influence the health of vast numbers of
people.
However, there is a long way to go before health
professionals can understand features of city living well
enough to be able to improve the health of urban dwellers.
There are several barriers to the study of urban health as a
cogent discipline. First, urban health is currently the
domain of multiple disciplines. Urban planners can bring to
the field perspectives about city design and how this might
affect behaviour and even wellbeing in cities. Urban
sociologists study interactions in densely populated cities.
Epidemiologists document the burden of disease in urban
areas and the factors associated with those diseases.
Unfortunately, these disciplines seldom speak the same
academic language and tremendous barriers exist to true
cross-disciplinary work. There is no common vocabulary
for urban health. Different disciplines have used words such
as urbanism, urbanisation, and urbanicity to represent
different concepts, hindering the ability of different
disciplines to learn from one another. Second, and perhaps
curiously, although there have recently been several
academic exercises devoted to rural health, there has been
little effort concentrated at bringing together researchers
and practitioners from different disciplines who can
illuminate understanding of key issues in the discipline.
A meeting11 at the New York Academy of Medicine, New
York City, on Oct 15–17, 2003, co-sponsored by several
academic and public-health institutions worldwide, will be
the second in a series attempting to lay the foundations for
the proposed discipline of urban health. Questions that will
be addressed include: what is urban health and how should
different aspects of urban living be considered as potential
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against smallpox just over 200 years ago by Edward Jenner,
a physician and natural scientist in the west of England, was
the decisive breakthrough that laid the basis for the eventual
eradication of the disease. By the early 1950s smallpox was
no longer endemic in Europe, but there were still 50 million
new cases worldwide each year.3 Smallpox was devastating;
about 30% of those affected died of the disease and the rest
were left scarred and often blinded. Less than 30 years later
the disease was declared eradicated by WHO after a global
vaccination programme. WHO has delayed the destruction
of the remaining stocks of variola virus so that further
research can be done if needed.
Concern about the possible deliberate release of smallpox
as a form of bioterrorism has led to the development of con-
tingency plans in several countries. In England the plan in-
cludes the vaccination of teams of health professionals who
would be called on if deliberate release of the virus was sus-
pected.4 The principles of the management of a smallpox
incident would still be isolation of cases and vaccination of
contacts. So, after 200 years, the pioneering work of Jenner
remains the basis of public protection against this important
disease.
Jenner was perhaps the first international medical hero
and was appropriately honoured in many countries
worldwide. But his memory has been neglected in his own
country.5 Jenner was born and died in the village of
Berkeley in Gloucestershire, where, in the course of his
medical practice, he developed vaccination. The house
where he lived contains an impressive museum dedicated to
his memory.6 A committed international effort, in which the
USA and Russia were the major financial contributors, led
to the erection of a statue of Jenner in Trafalgar Square in
1858, some 36 years after his death. The statue was not
permitted to remain in the square however, since it was felt
that such a prominent place should be reserved for heroes
of the process of taking lives in the course of gaining martial
glory, rather than for a doctor engaged in saving lives.
Despite opposition from the British Medical Journal,7 after
only 4 years the statue was banished to Kensington
Gardens in London.
The eradication of smallpox in 1980 is arguably the
greatest achievement of humankind. How fitting it would
be if the memory of the man whom we have to continue to
thank for keeping us safe should be honoured by putting his
statue back where it rightly belongs.
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determinants of health? What are the fundamental
characteristics of the urban physical and social environment
that might affect health? What are the public-health
interventions that could improve the health of urban
populations? And how can urban health become
consolidated as a discipline, and how can a body of theory
and practice be taught effectively to health professionals?
We are co-chairs of the second international conference on urban health.
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Putting Jenner back in his place
Debate about what statues
should or should not be in
one of the most famous
public places in the world,
Trafalgar Square in London,
recently resumed with the
announcement by the
Greater London Authority of
the sculptors who have been
shortlisted to create a
contemporary artwork to
occupy an empty plinth.1 The
square has recently been
remodelled, and the Mayor of
London advocates the
erection of a permanent
statue of Nelson Mandela in
it.2 But perhaps the time has
come to reverse the un-
ceremonious eviction from
the square of the statue
(figure) of an international
medical hero (which used to
be on different plinth).
The development of an
effective form of vaccination
Edward Jenner’s statue in
Kensington Gardens, London, UK Ra
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